CAR-T Therapy Pipeline Analysis 2021 Shows Growth Of The Market At A Rate Of Almost 30%

CAR-T Therapy Pipeline Analysis Market Report 2021: COVID 19 Growth And Change To 2030

CAR-T Therapy Pipeline Analysis Global Market Report 2021: COVID 19 Growth And Change To 2030

The Business Research Company’s CAR-T Therapy Pipeline Analysis Global Market Report 2021: COVID 19 Growth And Change to 2030

LONDON, GREATER LONDON, UK, February 16, 2021 /EINPresswire.com/ — New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

The global CAR-T therapy pipeline analysis market is expected to grow from $1.08 billion in 2020 to $1.4 billion in 2021 at a compound annual growth rate (CAGR) of 29.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global CAR-T therapy market is expected to reach $3.15 billion in 2025 at a CAGR of 22%.

North America was the largest region in the global CAR-T therapy pipeline analysis market, accounting for 61% of the market in 2020. Western Europe was the second largest region accounting for 38% of the CAR-T cell therapy market.

The chimeric antigen receptor T-cell therapy market consists of sales of CAR-T therapy products and related services by entities (organizations, sole traders and partnerships) that develop chimeric antigen receptor (CAR) T-cell therapies to treat blood cancers. CAR-T therapy is type of immunotherapy in which T-cells taken from a patient’s blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as chimeric antigen receptor (CAR), attaches to a specific protein on a patient’s cancer cells. The infused cells multiply and prevail in the patient’s body as living drugs.

The major players covered in the cell therapy CAR-T market are Novartis AG, Kite Pharma, Pfizer Inc, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Mustang Bio, Immune Therapeutics, Atara Biotherapeutics, Aurora Biopharma Inc., Eureka Therapeutics, Autolus, TILT Biotherapeutics, Fortress Biotech., Autolus Therapeutics PLC, bluebird bio, Carina Biotech, CARTherics, Endocyte, Inc., F1 Oncology, Inc., Fate Therapeutics Inc., Gilead, Oxford BioMedica PLC., PeproMene Bio Inc., Tessa Therapeutics Pte Ltd., TILT Biotherapeutics Ltd.

CAR-T Therapy Pipeline Analysis Global Market Report 2021: COVID 19 Growth And Change to 2030 is one of a series of new reports from The Business Research Company that provides CAR-T therapy pipeline analysis market overview, forecast CAR-T therapy pipeline analysis market size and growth for the whole market, CAR-T therapy pipeline analysis market segments, and geographies, CAR-T therapy pipeline analysis market trends, CAR-T therapy pipeline analysis market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global CAR-T Therapy Pipeline Analysis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3789&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

CAR-T Therapy Market – By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/car-t-therapy-market

Cell And Gene Therapy Global Market Report 2020-30: COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-global-market-report-2020-30-covid-19-growth-and-change

Stem Cell Therapy Market Global Report 2020-30: Covid 19 Growth and Change
https://www.thebusinessresearchcompany.com/report/stem-cell-therapy-market-global-report-2020-30-covid-19-growth-and-change

HER2 Inhibitors Market Global Report 2020-30: COVID 19 Growth And Change
https://www.thebusinessresearchcompany.com/report/her2-inhibitors-market-global-report-2020-30-covid-19-growth-and-change

Cellular Immunotherapy Global Market Report 2021: COVID 19 Growth And Change to 2030
https://www.thebusinessresearchcompany.com/report/cellular-immunotherapy-global-market-report-2020-30-covid-19-growth-and-change

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Leave a Reply

Your email address will not be published.